financing
Mirxes Gets $40M Financing From CBC Group's R-Bridge to Support Global Expansion
The company is developing blood-based microRNA tests for early cancer detection and screening, with its flagship assay, GastroClear, already approved as an IVD in Singapore.
Geneoscopy Closes $105M Series C Financing Led by Bio-Rad to Market CRC Screening Test
Geneoscopy will also work with Labcorp to more broadly disseminate its stool-based test, which uses Bio-Rad's Droplet Digital PCR technology.
Israeli Liquid Biopsy Startup Senseera Raises $7.1M in Seed Round
The funding will help the company commercialize a blood-based liver transplant rejection test as it continues to push for its platform in other disease research.
Bionano Genomics Restructures Debt, Initiates $10M Direct Offering
The optical genome mapping firm deferred its December 2024 amortization payment and reduced payments in the first half of 2025 to improve its cash position, and separately announced a $10 million direct stock offering.
Cytek Biosciences Approves $50M Stock Repurchase Program for 2025
The new program will succeed an existing $50 million stock repurchase program that expires on Dec. 31.